|
| N-(4-methoxyphenyl)-2-[(6-nitro-1H-benzimidazol-2-yl)sulfanyl]acetamide |
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
| N-(4-methylphenyl)-2-[(5-nitro-1H-benzimidazol-2-yl)sulfanyl]acetamide |
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
| N-[3-(2-amino-1H-imidazol-5-yl)phenyl]heptanamide;hydrochloride |
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Bunders CA, et al. 2010. Bioorg Med Chem Lett |
|
| Heptanoic acid [4-(2-amino-3H-imidazol-4-yl)phenyl]amide hydrochloride |
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Bunders CA, et al. 2010. Bioorg Med Chem Lett |
|
| 3-(furan-2-ylmethyl)-2-(((5-hydroxy-1H-pyrazol-3-yl)methyl)thio)-6,7-dihydro-3H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4(5H)-one |
|
Acinetobacter
Salmonella |
Biofilm
Biofilm |
Preclinical (in vitro)
Preclinical (in vitro) |
Koopman JA, et al. 2015. Antimicrob Agents Chemother
|
|
| 5-Hydroxyindole |
|
Salmonella
Shigella |
TTSS (SPI-1 encode)
TTSS (Type III secretion system) |
Preclinical (in vitro)
Preclinical (in vitro) |
McShan AC, et al. 2016. ChemMedChem
Dey S, et al. 2017. ChemMedChem |
|
| Indole-3-acetic acid |
|
Salmonella |
TTSS (SPI-1 encode) |
Preclinical (in vitro) |
McShan AC, et al. 2016. ChemMedChem |
|
| 2-[4-[3-(furan-2-yl)-5-phenyl-1,2-oxazol-4-yl]phenyl]quinoline-4-carboxylic acid |
|
Escherichia
Salmonella |
TTSS (Type III secretion system)
TTSS (SPI-2 encode) |
Preclinical (in vitro)
Preclinical (in vitro) |
El Qaidi S, et al. 2018. Front Cell Infect Microbiol
|
|
| 4-Morpholinoaniline |
|
Salmonella
Shigella |
TTSS (SPI-1 encode)
TTSS (Type III secretion system) |
Preclinical (in vitro)
Preclinical (in vitro) |
McShan AC, et al. 2016. ChemMedChem
Dey S, et al. 2017. ChemMedChem |
|
| 4-{4-[(2E)-3-phenylprop-2-en-1-yl]piperazin-1-yl}-5H-pyrimido[5,4-b]indole |
|
Salmonella |
Biofilm |
Preclinical (in vitro) |
Robijns SC, et al. 2012. FEMS Immunol Med Microbiol |
|
| | | |
